scholarly journals Type-specific identification of influenza viruses A, B and C by the polymerase chain reaction

1992 ◽  
Vol 39 (1-2) ◽  
pp. 1-13 ◽  
Author(s):  
E.C.J. Claas ◽  
M.J.W. Sprenger ◽  
G.E.M. Kletera ◽  
R.Van Beek ◽  
W.G.V. Quint ◽  
...  
Keyword(s):  
Polymerase Chain Reaction ◽  
Influenza Viruses ◽  
Chain Reaction ◽  
Specific Identification ◽  
Polymerase Chain

Detection of Influenza Viruses in Throat Swab by Using Polymerase Chain Reaction

1991 ◽  
Vol 35 (3) ◽  
pp. 259-265 ◽  
Author(s):  
Akira Yamada ◽  
Jiro Imanishi ◽  
Etsuro Nakajima ◽  
Katsuhisa Nakajima ◽  
Setsuko Nakajima
Keyword(s):  
Polymerase Chain Reaction ◽  
Throat Swab ◽  
Influenza Viruses ◽  
Chain Reaction ◽  
Polymerase Chain

scholarly journals Multiplex Real-Time Reverse-Transcription Polymerase Chain Reaction Assays for Diagnostic Testing of Severe Acute Respiratory Syndrome Coronavirus 2 and Seasonal Influenza Viruses: A Challenge of the Phase 3 Pandemic Setting

2020 ◽  
Author(s):  
Fabiola Mancini ◽  
Fabrizio Barbanti ◽  
Maria Scaturro ◽  
Stefano Fontana ◽  
Angela Di Martino ◽  
...  
Keyword(s):  
Polymerase Chain Reaction ◽  
Severe Acute Respiratory Syndrome ◽  
Real Time ◽  
Reverse Transcription ◽  
Seasonal Influenza ◽  
Influenza Viruses ◽  
Activity Period ◽  
Clinical Samples ◽  
Chain Reaction ◽  
Polymerase Chain

Abstract Background Pandemic coronavirus disease 2019 (COVID-19) disease represents a challenge for healthcare structures. The molecular confirmation of samples from infected individuals is crucial and therefore guides public health decision making. Clusters and possibly increased diffuse transmission could occur in the context of the next influenza season. For this reason, a diagnostic test able to discriminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from influenza viruses is urgently needed. Methods A multiplex real-time reverse-transcription polymerase chain reaction (PCR) assay was assessed using 1 laboratory protocol with different real-time PCR instruments. Overall, 1000 clinical samples (600 from samples SARS-CoV-2–infected patients, 200 samples from influenza-infected patients, and 200 negative samples) were analyzed. Results The assay developed was able to detect and discriminate each virus target and to intercept coinfections. The limit of quantification of each assay ranged between 5 and 10 genomic copy numbers, with a cutoff value of 37.7 and 37.8 for influenza and SARS-CoV-2 viruses, respectively. Only 2 influenza coinfections were detected in COVID-19 samples. Conclusions This study suggests that multiplex assay is a rapid, valid, and accurate method for the detection of SARS-CoV-2 and influenza viruses in clinical samples. The test may be an important diagnostic tool for both diagnostic and surveillance purposes during the seasonal influenza activity period.

scholarly journals Development of a polymerase chain reaction assay for specific identification ofClostridium colinum

2008 ◽  
Vol 37 (2) ◽  
pp. 179-181 ◽  
Author(s):  
L. Bano ◽  
I. Drigo ◽  
K. S. Macklin ◽  
S. W. Martin ◽  
R. S. Miller ◽  
...  
Keyword(s):  
Polymerase Chain Reaction ◽  
Polymerase Chain Reaction Assay ◽  
Chain Reaction ◽  
Specific Identification ◽  
Polymerase Chain
Sign in / Sign up

Export Citation Format

Share Document